Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice.

Authors

Gabriela Calhoun
Li Wang
Luis E. F. Almeida, Children's National Medical Center, Washington, DCFollow
Nicholas Kenyon, Children's National Medical Center, Washington, DC
Nina Afsar
Mehdi Nouraie, Howard University
Julia C. Finkel, George Washington UniversityFollow
Zenaide M.N. Quezado, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

5-2015

Journal

European Journal of Pharmacology

Volume

754

Inclusive Pages

125-133

DOI

10.1016/j.ejphar.2015.02.027

Keywords

Anemia, Sickle Cell--complications; Dexmedetomidine--pharmacology; Dexmedetomidine--therapeutic use; Pain--complications; Pain--drug therapy; Pain Measurement--drug effects

APA Citation

Calhoun, G., Wang, L., Almeida, L. E. F., Kenyon, N., Afsar, N., (2015). Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice. European Journal of Pharmacology, 754, 125-133.

Peer Reviewed

1